Tag Archives: CINV

Anti-nausea agent ondansetron at 32-mg IV dosing may affect heart rhythm regularity

A single 32-mg intravenous (IV) dose of the anti-nausea drug ondansetron has been linked to increased heart rhythm irregularities, particularly QT-interval prolongation, according to a recent Drug Safety Communication issued by the United States Food & Drug Administration (FDA). Ondansetron is a very effective 5HT3 antagonist used in India and… 

Read more »
Posted in Non-Communicable Disease, Primary Care | Also tagged , , , , , , , , , , | Volume: | Leave a comment